|Reporting Organization:||Gavi, The Vaccine Alliance|
|Total Budget ($CAD):||$ 20,000,000|
|Timeframe:||September 5, 2017 - December 31, 2021|
|Sub-Saharan Africa - $ 20,000,000.00 (100.00%)|
|Infectious & Communicable Diseases (100 %)|
This project aims to address gaps in immunization coverage and equity in Francophone countries of Africa which have some of the lowest immunization rates in the world. To do so, the project is scaling-up proven private sector innovations. It utilizes Gavi’s INFUSE platform (Innovation for Uptake, Scale and Equity in Immunization), which provides a space for selected innovators to present proven innovations that address bottlenecks and gender barriers in immunization systems in the poorest countries. The project seeks to leverage the INFUSE platform to target high-impact innovations from among the INFUSE innovators (“pacesetters”). Some key activities include: (1) providing support and business coaching, including oversight and assistance for partnership development to INFUSE pacesetters; (2) providing assistance to INFUSE pacesetters to develop a comprehensive monitoring and evaluation framework; and (3) engaging current and prospective Gavi donors in developing programs and strategies that strengthen the role of innovations in immunization delivery, coverage and equity.
|Gender and age:||Adult women Adolescent females Under-5 children Newborns|
|Total Direct Population:||Unspecified|
UnspecifiedReturn to top
The expected outcome for this project is: increased uptake, scale-up and/or integration of gender-sensitive innovations targeting barriers, particularly gender-related barriers, to vaccination, for women, infants, adolescent girls and underserved populations in targeted Gavi-eligible Francophone countries in Africa.